Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 7Breast Neoplasms 7Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Recurrence 3Pancreatic Neoplasms 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Congenital Abnormalities 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2

Interventions

Carboplatin 3Radiotherapy 2Doxorubicin 2tipifarnib 1etoposide phosphate 1becatecarin 1Vincristine 1Temozolomide 1Tamoxifen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1RMP 7 1Perfusion Magnetic Resonance Imaging 1Oxaliplatin 1Megestrol Acetate 1Lenalidomide 1Irinotecan 1Immunologic Techniques 1Etoposide 1Endostatins 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Cyproheptadine 1Cisplatin 1Cilengitide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Optic Nerve Glioma × tipifarnib × Clear all
NCT00070525 2013-10-08

Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma

National Cancer Institute (NCI)

Phase 2 Completed
90 enrolled
CNS

Astrocytoma, Medulloblastoma, Oligodendroglioma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡